At the functional level, antibody- or siRNA-mediated inhibition of CD26/DPP4 in the CD26+ T-ALCL (anaplastic large cell lymphoma) line Karpas-299 resulted in decreased adhesion properties in vitro and improved survival in vivo [109]. Here, DPP4 is linked to anaplastic large cell lymphoma.